Within that study, it was found that mutations in the TERT promoter occurred significantly more often in IDH1 wildtype glioblastomas (187 out of 322; 58%) compared to IDH1-mutated gliomas (10 out of 36; 28%; p = 0.0056) [39,118]. This evidence concerns the gene TERT and central nervous system cancer.